Detalles de la búsqueda
1.
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.
Acta Derm Venereol
; 101(3): adv00422, 2021 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269404
2.
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.
Acta Derm Venereol
; 101(10): adv00576, 2021 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903916
3.
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization.
Graefes Arch Clin Exp Ophthalmol
; 257(4): 759-768, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680452
4.
Pharmacological approach and adherence to treatment recommendations in frequently and non-frequently exacerbating COPD patients from Italy: MISTRAL - The prospective cohort, observational study.
Pulm Pharmacol Ther
; 53: 68-77, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30193866
5.
Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA - an observational, 2 phase, patient reported outcomes study.
Clin Mol Allergy
; 13(1): 10, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26155196
6.
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN).
J Neurol
; 270(11): 5600-5612, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37550498
7.
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study.
Clin Cosmet Investig Dermatol
; 16: 27-38, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636635
8.
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.
Clin Cosmet Investig Dermatol
; 16: 847-852, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37033782
9.
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
Clin Cosmet Investig Dermatol
; 16: 3561-3574, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38107670
10.
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study.
Eur J Dermatol
; 31(5): 630-637, 2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789441
11.
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis.
Clin Transl Allergy
; 10: 25, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32607141
12.
Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study.
World Allergy Organ J
; 13(1): 100095, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015785
13.
Patient-reported outcomes in elderly patients with type 2 diabetes mellitus treated with dual oral therapy: a multicenter, observational study from Italy.
Curr Med Res Opin
; 36(4): 555-562, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31868033
14.
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod.
J Neurol Sci
; 405: 116423, 2019 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31520869
15.
Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study.
Respir Med
; 138: 88-94, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29724399
16.
Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study.
World Allergy Organ J
; 11(1): 33, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30410639
17.
Multicentre observational study evaluating immediate and progressive switching from carbamazepine to oxcarbazepine in patients with epilepsy.
Funct Neurol
; 22(2): 111-5, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17637215
18.
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).
J Neurol
; 264(12): 2436-2449, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063244
19.
Clinical experience with daptomycin in Italy: results from a registry study of the treatment of Gram-positive infections between 2006 and 2009.
J Chemother
; 24(2): 113-21, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22546768
20.
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.
Transplantation
; 88(10): 1194-202, 2009 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-19935373